Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01XOther antineoplastic agents
- Chemical subgroupL01XH
- Chemical substanceL01XH03Panobinostat
L01XX42
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Spain
AEMPS · 3 registrations
Netherlands
CBG-MEB · 3 registrations
At a glance
- ATC code
- L01XH03, L01XX42
- Registers
- 5
- Historical lists
- 1
- Registrations
- 12
- With their own page
- 9
- Companies
- 4
All medicines with Panobinostat
Human medicines from every register that match Panobinostat by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
12 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Farydak | United States | 10MG BASE, 15MG BASE, 20MG BASE | capsule | Not marketed | Secura |
| Farydak | European Union | Authorised | pharmaand GmbH | ||
| Farydak 10 MG Capsulas Duras | Spain | 12,576 mg | cápsula dura | Authorised | Pharmaand Gmbh |
| Farydak 10 mg harde capsules | Netherlands | Capsule, hard | Authorised | zr pharma& GmbH | |
| Farydak 15 MG Capsulas Duras | Spain | 18,864 mg | cápsula dura | Authorised | Pharmaand Gmbh |
| Farydak 15 mg harde capsules | Netherlands | Capsule, hard | Authorised | zr pharma& GmbH | |
| Farydak 20 MG Capsulas Duras | Spain | 25,152 mg | cápsula dura | Authorised | Pharmaand Gmbh |
| Farydak 20 mg harde capsules | Netherlands | Capsule, hard | Authorised | zr pharma& GmbH | |
| Farydak | Croatia | Authorised | |||
| FARYDAK 10 mg | Romania | 10mg | caps. | Status unknown | Novartis Europharm Limited |
| FARYDAK 15 mg | Romania | 15mg | caps. | Status unknown | Novartis Europharm Limited |
| FARYDAK 20 mg | Romania | 20mg | caps. | Status unknown | Novartis Europharm Limited |